These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23662746)

  • 1. Improving knowledge about prenatal screening options: can group education make a difference?
    Knutzen DM; Stoll KA; McClellan MW; Deering SH; Foglia LM
    J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1799-803. PubMed ID: 23662746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health literacy and patient understanding of screening tests for aneuploidy and neural tube defects.
    Cho RN; Plunkett BA; Wolf MS; Simon CE; Grobman WA
    Prenat Diagn; 2007 May; 27(5):463-7. PubMed ID: 17345585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of experiential knowledge on prenatal screening and testing decisions.
    Etchegary H; Potter B; Howley H; Cappelli M; Coyle D; Graham I; Walker M; Wilson B
    Genet Test; 2008 Mar; 12(1):115-24. PubMed ID: 18307384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome.
    Jaques AM; Collins VR; Muggli EE; Amor DJ; Francis I; Sheffield LJ; Halliday JL
    Prenat Diagn; 2010 Jun; 30(6):522-30. PubMed ID: 20509151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies.
    Stefansdottir V; Skirton H; Jonasson K; Hardardottir H; Jonsson JJ
    Acta Obstet Gynecol Scand; 2010 Jul; 89(7):931-8. PubMed ID: 20235896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum screening.
    Lofsky S
    CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening--a randomized controlled trial.
    Björklund U; Marsk A; Levin C; Öhman SG
    Patient Educ Couns; 2012 Mar; 86(3):390-5. PubMed ID: 21807474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Written patient information about triple-marker screening: a randomized, controlled trial.
    Glazier R; Goel V; Holzapfel S; Summers A; Pugh P; Yeung M
    Obstet Gynecol; 1997 Nov; 90(5):769-74. PubMed ID: 9351762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed consent: providing information about prenatal examinations.
    Dahl K; Kesmodel U; Hvidman L; Olesen F
    Acta Obstet Gynecol Scand; 2006; 85(12):1420-5. PubMed ID: 17260215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genetic counseling and prenatal diagnosis for Down syndrome and neural tube defects.
    Swerts A
    Birth Defects Orig Artic Ser; 1987; 23(2):61-83. PubMed ID: 2954594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
    Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.
    Chetty S; Garabedian MJ; Norton ME
    Prenat Diagn; 2013 Jun; 33(6):542-6. PubMed ID: 23592525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of prenatal group genetic counselling on knowledge, anxiety and decisional conflict: issues for nuchal translucency screening.
    Kaiser AS; Ferris LE; Pastuszak AL; Llewellyn-Thomas H; Johnson JA; Conacher S; Shaw BF
    J Obstet Gynaecol; 2002 May; 22(3):246-55. PubMed ID: 12521493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.